The New York Times Reports on Experimental Treatment for Leukemia
Published on
The New York Times features a story on Emma Whitehead, the first child to receive CTL019, an experimental leukemia treatment.
Emma's cancer had relapsed twice, and looking for more options, her parents brought her to The Children's Hospital of Philadelphia. Their daughter was soon enrolled in this study of a targeted cellular therapy.
Categories: CTL019